The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
HCPLive Staff
Advertisement
Articles by HCPLive Staff
The FDA has approved a supplemental new drug application for avanafil (Stendra) to treat erectile dysfunction in men.
Advertisement
Latest Updated Articles
- FDA Approves sNDA for Oral Erectile Dysfunction Treatment
Published: September 18th 2014 | Updated:
- FDA Approves Alemtuzumab for Relapsing Forms of Multiple Sclerosis
Published: November 15th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
3
Court Ruling Highlights Risks of Improper Dose Adjustments
4
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
5
